Mellitor

Company Overview

Snapshot

Founded in September 2006 by Doron Goldberg, Mellitor operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of an implantable glucose sensor.

Business overview

Mellitor is a Health Tech & Life Sciences company developing an implantable glucose sensor for continuous monitoring in diabetic patients. Its core technology provides real-time, highly accurate measurements of glucose levels in interstitial fluid, designed for extended implantation similar to a pacemaker. The company also leverages its core technology for the development of an HPLC polarimeter, serving the medical devices and monitoring sectors.

Company Intelligence Q&A

What is Mellitor's primary focus?

Mellitor is primarily focused on developing an implantable glucose sensor for the continuous monitoring of glucose levels in patients with diabetes.

Who is a key founder of Mellitor?

Doron Goldberg is a co-founder and CTO of Mellitor.

What is the core technology behind Mellitor's product?

Mellitor's core technology involves a sensor designed for extended implantation that provides real-time, highly accurate measurements of glucose levels in interstitial fluid.

In which sector does Mellitor operate?

Mellitor operates within the Health Tech & Life Sciences sector, specifically focusing on medical devices and monitoring solutions.

What is Mellitor's current product development stage?

Mellitor is currently in the R&D stage for its implantable glucose sensor and is also utilizing its core technology for an HPLC polarimeter.